|
|
|
 Profile
|
 |
|
To improve the quality of life for patients by providing them with products which are Safe, Effective, High Quality and Affordable price.
Bal Pharma is a fully integrated and leading Indian Pharmaceutical Company specializing in Prescription drugs, Generic, OTC products, Intravenous Infusion and Bulk Actives with almost 19 years of experience behind it.
Bal Pharma’s API’s and Formulations are produced at world class manufacturing facilities. API’s are exported to Europe, Latin America, Africa, Middle East and Asian markets. Formulation products are exported to Semi-Regulated and Non Regulated markets and s strong contender for Tender business in various markets especially Asian markets.
With the new facility being set up in Uttaranchal, as per ICH and PIC guidelines to meet the requirements of USFDA and various European MOH, the company plans to enter in to Regulated Markets by 2010 and already in talks for Contract Manufacturing for clients in Regulated Markets. Successful Operations in Domestic and International markets, backed by its strength in Research and strong Infrastructure frame work have accelerated Bal Pharma’s growth from oblivience to reach a turn over of USD 25 million today. Buoyed by the past, the group has put in motion a fast track growth target and has set its sigh on sales in excess of USD 150 million by 2015. |
|
Our Vision |
|
|
| To be Global Research Driven Company with a strong R & D pipeline. |
| |
| |
| |
| |
|
Our Mission |
|
|
| Is dedicated to the pursuit of providing better and healthy lifestyle through quality products and innovation. |
| |
| |
| |
| |
|
Our Business |
|
|
|
|
Senior Management Team
|
|
|
|
|
 |
| Senior Management Team |
|
|
|
|
Code of Conduct
|
|
|
|
CODE OF CONDUCT FOR BOARD MEMBERS
The Board shall collectively:
Strive to keep in view and maintain appropriate balance on the
interests of all its stakeholders in all its deliberations and
decisions.
Place highest priority for statutory compliance.
Strive its best for unanimous decisions; wherever unavoidable
permit constructive and healthy dissent.
A Board member shall individually:
Place Company's interests above his personal
interests; where, on a subject, there is a clash of interest, he
shall provide complete disclosure and refrain from participating in
the discussions on the subject.
Strive to give his best attention, time and efforts to the
interests of the Company and attend all meetings of the Board and
its sub-committees regularly and participate constructively in all
deliberations. |
|
|
|
